{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:42:44Z","timestamp":1792759364683,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007602","name":"National Institute for Health Research Programme Grants for Applied Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clon.2026.104342","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:39:44Z","timestamp":1789627184000},"page":"104342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Drivers of Change in Radiotherapy Practice: Lessons From a UK Tertiary Cancer Centre (2013\u20132023)"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8272-7901","authenticated-orcid":false,"given":"A.","family":"Kapadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-3360","authenticated-orcid":false,"given":"G.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9781","authenticated-orcid":false,"given":"C.","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Holley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1832-548X","authenticated-orcid":false,"given":"K.","family":"Banfill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-9732","authenticated-orcid":false,"given":"G.","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-4275","authenticated-orcid":false,"given":"T.","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Radhakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-2488","authenticated-orcid":false,"given":"J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-5562","authenticated-orcid":false,"given":"C.","family":"Anandadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-4329","authenticated-orcid":false,"given":"G.A.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-7804","authenticated-orcid":false,"given":"D.P.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2026.104342_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clon.2026.104342_bib2","doi-asserted-by":"crossref","first-page":"s163","DOI":"10.21037\/tlcr.2019.08.12","article-title":"What is the optimal radiotherapy utilization rate for lung cancer?-a systematic review","volume":"8","author":"Liu","year":"2019","journal-title":"Transl Lung Cancer Res"},{"issue":"1152","key":"10.1016\/j.clon.2026.104342_bib3","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20230334","article-title":"The use of radiotherapy, surgery and chemotherapy in the curative treatment of cancer: results from the FORTY (Favourable Outcomes from RadioTherapY) project","volume":"96","author":"Mee","year":"2023","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41416-018-0201-z","article-title":"Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?","volume":"119","author":"Thompson","year":"2018","journal-title":"Br J Cancer"},{"issue":"1104","key":"10.1016\/j.clon.2026.104342_bib5","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190524","article-title":"The evolving role of radiotherapy in non-small cell lung cancer","volume":"92","author":"Brown","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2026.104342_bib6","series-title":"Radiotherapy and its consequences: what the cardiologist should know","author":"Aznar","year":"2021"},{"key":"10.1016\/j.clon.2026.104342_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2021.09.026","article-title":"50 years of radiotherapy research: Evolution, trends and lessons for the future","volume":"165","author":"Berger","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1007","key":"10.1016\/j.clon.2026.104342_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: a review of current literature and clinical use in practice","volume":"84","author":"Teoh","year":"2011","journal-title":"Br J Radiol"},{"issue":"1102","key":"10.1016\/j.clon.2026.104342_bib9","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190270","article-title":"Complexity metrics for IMRT and VMAT plans: a review of current literature and applications","volume":"92","author":"Chiavassa","year":"2019","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.clon.2026.104342_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00066-024-02281-z","article-title":"Artificial intelligence for response prediction and personalisation in radiation oncology","volume":"201","author":"Zwanenburg","year":"2025","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"10.1016\/j.clon.2026.104342_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00066-025-02381-4","article-title":"The increasing role of artificial intelligence in radiation oncology: how should we navigate it?","volume":"201","author":"Putz","year":"2025","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib12","article-title":"Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines","volume":"29","author":"Noy","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.radonc.2021.09.030","article-title":"Learning healthcare systems and rapid learning in radiation oncology: Where are we and where are we going?","volume":"164","author":"Price","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111165","article-title":"Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature","volume":"213","author":"Vandemaele","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib15","article-title":"Evidence-based practice in oncology when it suits us?","volume":"2","author":"Hoskin","year":"2023","journal-title":"BMJ Oncol"},{"issue":"13","key":"10.1016\/j.clon.2026.104342_bib17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample Size in Qualitative Interview Studies: Guided by Information Power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual Health Res"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G","article-title":"Whatever happened to qualitative description?","volume":"23","author":"Sandelowski","year":"2000","journal-title":"Res Nurs Health"},{"issue":"13","key":"10.1016\/j.clon.2026.104342_bib19","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/1049732316654870","article-title":"Member Checking: A Tool to Enhance Trustworthiness or Merely a Nod to Validation? A Tool to Enhance Trustworthiness or Merely a Nod to Validation?","volume":"26","author":"Birt","year":"2016","journal-title":"Qual Health Res"},{"key":"10.1016\/j.clon.2026.104342_bib20","series-title":"Thematic analysis: a practical guide","author":"Braun","year":"2022"},{"key":"10.1016\/j.clon.2026.104342_bib21","series-title":"Applied thematic analysis","author":"Guest","year":"2012"},{"key":"10.1016\/j.clon.2026.104342_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.11.031","article-title":"NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin\/capecitabine or carboplatin\/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma","volume":"74","author":"Mukherjee","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104342_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2021.05.020","article-title":"Oxaliplatin\/capecitabine or carboplatin\/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial","volume":"153","author":"Mukherjee","year":"2021","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clon.2022.03.019","volume":"34","author":"Bridges","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2026.104342_bib25","series-title":"Stereotactic ablative radiotherapy for hepatocellular carcinoma (adults)","year":"2020"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22070","volume":"22","author":"Ghaneh","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clon.2026.104342_bib27","series-title":"Pancreatic cancer in adults: diagnosis and management","year":"2018"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijrobp.2010.09.038","article-title":"Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: Implications for the management of head-and-neck cancers","volume":"82","author":"Campbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104342_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0002-9610(97)00282-1","article-title":"Clinicopathological analysis of local spread of carcinoma of the tongue","volume":"175","author":"Yuen","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.clon.2026.104342_bib31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.canrad.2014.04.006","article-title":"Microscopic extensions of head and neck squamous cell carcinomas: Impact for clinical target volume definition","volume":"18","author":"Fleury","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.clon.2026.104342_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2017.09.019","article-title":"Effect of introducing geometric GTV to CTV margins expansion in national contouring guidelines for head and neck radiotherapy","volume":"126","author":"Hansen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib33","series-title":"Head and neck cancer: consensus Statements","year":"2022"},{"issue":"8","key":"10.1016\/j.clon.2026.104342_bib34","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1470-2045(23)00265-6","article-title":"Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial","volume":"24","author":"Nutting","year":"2023","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.clon.2026.104342_bib35","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-NECK Trial Management Group. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.clon.2026.104342_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21170","volume":"21","author":"Mehanna","year":"2017","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-8140(24)00504-8","article-title":"139 Hypofractionated radiotherapy to the larynx is effective and well tolerated in T1 glottic larynx carcinoma","volume":"192","author":"Goyal","year":"2024","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2026.104342_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2013.06.2044","article-title":"Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK\/01\/004)","volume":"87","author":"Huddart","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"33","key":"10.1016\/j.clon.2026.104342_bib39","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2010.28.4950","article-title":"Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma","volume":"28","author":"Hoskin","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2026.104342_bib40","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ijrobp.2021.03.001","article-title":"Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399)","volume":"110","author":"Song","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104342_bib41","series-title":"Bladder cancer: diagnosis and management","year":"2015"},{"issue":"2","key":"10.1016\/j.clon.2026.104342_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","article-title":"Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials","volume":"22","author":"Choudhury","year":"2021","journal-title":"Lancet Oncol"},{"issue":"10260","key":"10.1016\/j.clon.2026.104342_bib43","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.annonc.2024.03.010","article-title":"Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)","volume":"35","author":"Parker","year":"2024","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clon.2026.104342_bib45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2024.07.026","article-title":"Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)","volume":"86","author":"Parker","year":"2024","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib46","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10196","key":"10.1016\/j.clon.2026.104342_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clon.2026.104342_bib48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.eururo.2024.08.030","article-title":"Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial","volume":"86","author":"van As","year":"2024","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijrobp.2023.08.027","article-title":"5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer","volume":"117","author":"van As","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.clon.2026.104342_bib50","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib51","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(25)00205-0","article-title":"Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial","volume":"26","author":"Tree","year":"2025","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clon.2026.104342_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003998","article-title":"Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial","volume":"19","author":"Parker","year":"2022","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.clon.2026.104342_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1470-2045(23)00148-1","article-title":"Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol","volume":"24","author":"Attard","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10071","key":"10.1016\/j.clon.2026.104342_bib54","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bju.14361","article-title":"National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting","volume":"122","author":"Brizmohun","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2026.104342_bib56","series-title":"Prostate cancer: diagnosis and management","year":"2021"},{"key":"10.1016\/j.clon.2026.104342_bib57","series-title":"Evidence-based indications for the use of PET-CT in the United Kingdom","year":"2022"},{"key":"10.1016\/j.clon.2026.104342_bib58","series-title":"Commissioning policy. Prostate-specific Membrane antigen (PSMA) radiotracers in Positron emission tomography \u2013 computed tomography (PETCT) imaging for individuals with high-risk primary or recurrent prostate cancer (adults)","year":"2025"},{"issue":"10237","key":"10.1016\/j.clon.2026.104342_bib59","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"FAST-Forward Trial Management Group. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2026.104342_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110915","article-title":"Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study","volume":"207","author":"Brunt","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib61","series-title":"Postoperative radiotherapy for breast cancer hypofractionation","year":"2021"},{"issue":"10099","key":"10.1016\/j.clon.2026.104342_bib62","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib63","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1470-2045(25)00194-9","article-title":"Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial","volume":"26","author":"Kirby","year":"2025","journal-title":"Lancet Oncol"},{"issue":"10394","key":"10.1016\/j.clon.2026.104342_bib64","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/S0140-6736(23)00619-0","article-title":"Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial","volume":"401","author":"Coles","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clon.2026.104342_bib65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib66","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clon.2026.104342_bib68","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional Nodal Irradiation in Early-Stage Breast Cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib70","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1200\/JCO.2015.63.6456","article-title":"DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer","volume":"34","author":"Thorsen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"36","key":"10.1016\/j.clon.2026.104342_bib71","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.22.00044","article-title":"Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study","volume":"40","author":"Thorsen","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib72","series-title":"Postoperative radiotherapy for breast cancer hypofractionation","year":"2016"},{"issue":"36","key":"10.1016\/j.clon.2026.104342_bib73","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2016.69.1188","article-title":"Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update","volume":"34","author":"Recht","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10384","key":"10.1016\/j.clon.2026.104342_bib74","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(23)00285-4","article-title":"Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials","volume":"401","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clon.2026.104342_bib75","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2013.04.021","article-title":"The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy","volume":"108","author":"Bartlett","year":"2013","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib76","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.radonc.2014.11.018","article-title":"The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery","volume":"114","author":"Bartlett","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2026.104342_bib77","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.clon.2016.11.005","article-title":"The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy","volume":"29","author":"Bartlett","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2026.104342_bib78","series-title":"Early and locally advanced breast cancer: diagnosis and management","year":"2025"},{"issue":"12","key":"10.1016\/j.clon.2026.104342_bib79","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.18.01765","article-title":"Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma","volume":"37","author":"Merchant","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2026.104342_bib80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/neuonc\/noaa222.187","article-title":"EPEN-54. ACNS0831, Phase III randomized trial of post-radiation chemotherapy in patients with newly diagnosed ependymoma ages 1 to 21 years","volume":"22","author":"Smith","year":"2020","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of Radiosurgery Alone vs Radiosurgery with Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clon.2026.104342_bib82","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clon.2026.104342_bib83","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.clon.2026.104342_bib84","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.clon.2026.104342_bib85","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-8140(11)70363-2","article-title":"First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015)","volume":"100","author":"Fast","year":"2011","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.clon.2026.104342_bib88","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3109\/0284186X.2015.1067719","article-title":"The evaluation of innovation in radiation oncology--what can we do and what should we do?","volume":"54","author":"Pignol","year":"2015","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib89","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.3390\/curroncol30070510","article-title":"Twenty Years of Advancements in a Radiotherapy Facility: Clinical Protocols, Technology, and Management","volume":"30","author":"Tomatis","year":"2023","journal-title":"Curr Oncol"},{"issue":"7","key":"10.1016\/j.clon.2026.104342_bib90","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/1878-0261.12659","article-title":"Technology-driven research for radiotherapy innovation","volume":"14","author":"Fiorino","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111264","article-title":"The concept of virtual clinical trials: A game changer in radiation oncology research?","volume":"214","author":"Faivre-Finn","year":"2026","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib92","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fonc.2017.00059","article-title":"R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology","volume":"7","author":"Verkooijen","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2024.08.005","article-title":"Artificial Intelligence for Radiation Treatment Planning: Bridging Gaps from Retrospective Promise to Clinical Reality","volume":"37","author":"Conroy","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2026.104342_bib94","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.phro.2020.11.002","article-title":"Machine learning applications in radiation oncology: Current use and needs to support clinical implementation","volume":"16","author":"Brouwer","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1137803","article-title":"Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning","volume":"13","author":"Lucido","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110345","article-title":"A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy","volume":"197","author":"Hurkmans","year":"2024","journal-title":"Radiother Oncol"},{"issue":"15","key":"10.1016\/j.clon.2026.104342_bib97","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.21.02810","article-title":"The Time Toxicity of Cancer Treatment","volume":"40","author":"Gupta","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib98","article-title":"Clinical adoption of deep learning target auto-segmentation for radiation therapy: challenges, clinical risks, and mitigation strategies","volume":"1","author":"De Biase","year":"2024","journal-title":"BJR Artif Intell"},{"key":"10.1016\/j.clon.2026.104342_bib99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-12-16","article-title":"Effects on patients of their healthcare practitioner's or institution's participation in clinical trials: a systematic review","volume":"12","author":"Clarke","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.clon.2026.104342_bib100","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241303606","article-title":"Synthesizing Efficiency Tools in Radiotherapy to Increase Patient Flow: A Comprehensive Literature Review","volume":"18","author":"Ramiah","year":"2024","journal-title":"Clin Med Insights Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clon.2021.10.009","article-title":"Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK","volume":"34","author":"Banfill","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"10.1016\/j.clon.2026.104342_bib102","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/S1470-2045(11)70379-5","article-title":"Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?","volume":"13","author":"van Loon","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clon.2026.104342_bib103","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clon.2021.12.017","article-title":"Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study","volume":"34","author":"Price","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.clon.2026.104342_bib104","article-title":"Feasibility of implementing a rapid-learning methodology to inform radiotherapy treatments: key professional stakeholders' views","volume":"3","author":"Kapadi","year":"2024","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.clon.2026.104342_bib105","article-title":"Challenges and opportunities for real-world evidence in clinical oncology-a view from the UK: proceedings of a national workshop","volume":"6","author":"Craddock","year":"2024","journal-title":"ESMO Real World Data Digit Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:57:27Z","timestamp":1792756647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":104,"alternative-id":["S0936655526003134"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104342","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drivers of Change in Radiotherapy Practice: Lessons From a UK Tertiary Cancer Centre (2013\u20132023)","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"104342"}}